RankingsPricing
  1. US-listed companies
  2. MEI Pharma, Inc.

MEI Pharma, Inc.MEIP

Market cap
$18.72M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Jun 30,
2012		Jun 30,
2013		Jun 30,
2014		Jun 30,
2015		Jun 30,
2016		Jun 30,
2017		Jun 30,
2018		Jun 30,
2019		Jun 30,
2020		Jun 30,
2021		Jun 30,
2022		Jun 30,
2023
Cash and cash equivalents636141911813101291617
Short-term investments--35453545896517014513884
Total cash, cash equivalents and short-term investments---64465410374183153153-
Other Receivables----------100
Other Receivables----------100
Prepaid expenses and other current assets000112226447
Prepaid expenses and other current assets000112226447
Total current assets6364964475510482209165167108
Total current assets6364964475510482209165167108
Operating lease right-of use assets---------8912
Property and equipment, net000000001221
Total assets6375065475610583210174178121
Accounts payable112111452686
Accrued liabilities11344335681112
Deferred revenue-----115151550
Operating lease liability---------111
Total current liabilities22556581423302420
Deferred revenue, long-term-------368739165
Operating lease liability, long term---------7911
Warrant liability------461840222-
Total liabilities------543513213312596
Preferred Stock, Value, Issued------------
Common Stock, Value, Issued------------
Additional paid-in-capital----219225265279355369427431
Accumulated deficit-85-96-123-156-177-174-214-231-277-328-374-406
Total stockholders' equity53545604251504878415225
Total liabilities and stockholders' equity6375065475610583210174178121